The diagnosis and treatment of acquired Myasthenia Gravis in two adult dogs using oral neostigmine bromide
Sri Lanka Veterinary Journal · 2016
DOI: 10.4038/slvj.v63i1.5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sri Lanka Veterinary Journal, 2016. Verfasst von D.R.A. Dissanayake und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Two adult dogs aged 3.5 and 9 years were diagnosed with acquired Myasthenia Gravis (MG) based on clinical signs and positive response to oral neostigmine bromide (0.25mg/Kg BW) within 4 hours of oral administration. Both patients were successfully treated using neostigmine (1mg/Kg BW daily) alone or with neostigmine (1mg/Kg BW daily) and prednisolone (1mg/Kg BW, q12h) combination. Serum alkaline phosphatase and albumin/ globulin ratio monitored in one of the above patients starting from one month prior to development of generalized clinical signs until complete recovery, showed significant alterations which can be used in diagnosing MG and in monitoring the response to treatment.
Zitieren
APA
Dissanayake, D., Silva, I., Senapathi, Y. D. S., Silva, D. D., Mallikarachchi, M., Gunathilaka, W., Kumara, W., Rajapaksha, E., & Fernando, W. (2016). The diagnosis and treatment of acquired Myasthenia Gravis in two adult dogs using oral neostigmine bromide. Sri Lanka Veterinary Journal. https://doi.org/10.4038/slvj.v63i1.5
Vancouver
Dissanayake D, Silva I, Senapathi YDS, Silva DD, Mallikarachchi M, Gunathilaka W, et al. The diagnosis and treatment of acquired Myasthenia Gravis in two adult dogs using oral neostigmine bromide. Sri Lanka Veterinary Journal. 2016. doi:10.4038/slvj.v63i1.5
BibTeX
@article{Dissanayake2016,
author = {Dissanayake, D.R.A. and Silva, I.D. and Senapathi, Y.U. De Silva and Silva, D.D.N. De and Mallikarachchi, M.D.H.S. and Gunathilaka, W.G.D.A. and Kumara, W.R.B. and Rajapaksha, E. and Fernando, W.C.R.},
title = {The diagnosis and treatment of acquired Myasthenia Gravis in two adult dogs using oral neostigmine bromide},
journal = {Sri Lanka Veterinary Journal},
year = {2016},
doi = {10.4038/slvj.v63i1.5}
}
EUVIMED